Skip to main content
. 2015 Aug 18;6(30):30232–30238. doi: 10.18632/oncotarget.4920

Figure 3. Kaplan-Meier estimates of survival for all 703 gliomas.

Figure 3

A. Progression free survival and overall survival among IDH1/2 mutant tumors stratified by relative Ki-67 expression level; B. Progression free survival and overall survival among IDH1/2 wild type tumors stratified by relative Ki-67 expression level.